Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence

We hypothesized (1) preclinical biologic evidence exists for the role of androgens in ovarian cancer development and (2) flutamide treatment of women at high risk (HR) for ovarian cancer may identify meaningful tissue biomarkers of androgen action and of ovarian cancer initiation. We showed that and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gruessner, Christine, Gruessner, Angelika, Glaser, Katherine, AbuShahin, Nisreen, Zhou, Yi, Laughren, Cynthia, Wright, Heather, Pinkerton, Samantha, Yi, Xiaofang, Stoffer, Jha'nae, Azodi, Masoud, Zheng, Wenxin, Chambers, Setsuko K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154987/
https://ncbi.nlm.nih.gov/pubmed/24950779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-13-0408
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados